Juvenile Paget’s disease in a 12-year-old Nigerian adolescent: a case report

Authors

  • Emmanuel Adeniji
  • Dr. Elizabeth E. Oyenusi University of Lagos image/svg+xml
  • Oluwadamilola Oladipo
  • Chioma Ahumaraeze
  • Taibat Raji
  • Magdalene Oyewusi
  • Monisola Ademoluti
  • Anulika Nwanekezie
  • Abiola Oduwole

DOI:

https://doi.org/10.30442/

Keywords:

Adolescents, Children, Hypercalcaemia, Hypophosphataemia, Paget’s disease

Abstract

Summary

Paget’s disease (PD) is a skeletal growth disorder characterised by highly elevated bone turnover and fast skeletal remodelling. Typically, PD is a rare disease, and it develops in the later stages of life, whereas Juvenile PD is ultra-rare. We report this 12-year-old female adolescent who presented with clinical, biochemical and radiological features that are in keeping with those of PD. Patient has been commenced on Zoledronic acid injection and outpatient follow-up appropriately. The case is being reported to show that PD, even though rare, does occur in Nigerian children, and clinicians need to be aware so that they can have a high index of suspicion when a similar presentation is encountered in clinical practice.

 

Author Biographies

  • Emmanuel Adeniji

    Consultant Paediatrician, Department of Paediatrics, Paediatric Endocrinology Training Centre for West Africa, 

  • Dr. Elizabeth E. Oyenusi, University of Lagos

    Consultant Paediatric Endocrinologist, Associate Professor, Endocrine and Metabolism Unit, Department of Paediatrics

  • Oluwadamilola Oladipo

    Senior Registrar, Department of Paediatrics

  • Chioma Ahumaraeze

    Consultant Paediatrician, Department of Paediatrics, Paediatric Endocrinology Training Centre for West Africa

  • Taibat Raji

    consultant paediatrician, department of Paediatrics, Paediatric Endocrinology Training Centre for West Africa

  • Magdalene Oyewusi

    consultant paediatrician, department of paediatrics, Paediatric and Endocrinology Training Centre for West Africa

  • Monisola Ademoluti

    Senior registrar, department of paediatrics

  • Anulika Nwanekezie

    senior registrar, department of paediatrics

  • Abiola Oduwole

    Professor of Paediatrics, Department of Paediatrics

References

1. Höppner J, Steff K, Misof BM, Schündeln MM, Hövel M, Lücke T, et al. Clinical course in two children with Juvenile Paget's disease during long-term treatment with intravenous bisphosphonates. Bone Rep. 2021;14:100762. doi: 10.1016/j.bonr.2021.100762.

2. Banaganapalli B, Fallatah I, Alsubhi F, Shetty PJ, Awan Z, Elango R, et al. Paget’s disease: a review of the epidemiology, etiology, genetics, and treatment. Front. Genet. 2023;14:1131182. doi: 10.3389/fgene.2023.1131182.

3. Horackova J, Taslerova R, Bayer M, et al. Juvenile Paget disease with unique compound heterozygous sequence variants in the TNFRSF11B gene. Orphanet J Rare Dis. 2025;20:409. https://doi.org/10.1186/s13023-025-03804-2

4. Indumathi CK, Dinakar C, Roshan R. Juvenile Paget’s Disease. Indian Pediatr. 2009;46:354-356.

5. Anjalji TN, Rajaratnam S, Shanthly N, Oommen R, Seshadri MS. Paget’s disease of bone: Experience from a center in Southern India. J Assoc Physicians India 2006;54: 525-529.

6. Ralston SH, Layfield R. Pathogenesis of Paget Disease of Bone. Calcif Tissue Int 2012; 91:97–113. https://doi.org/10.1007/s00223-012-9599-0.

7. Cundy T, Davidson J, Rutland MD, Stewart C, DePaoli AM. Recombinant osteoprotegerin for Juvenile Paget’s disease. NEJM 2005; 353: 918- 923.

8. Visconti MR, Usategui-Martín R, Ralston SH. Antibody response to paramyxoviruses in paget’s disease of bone. Calcif. Tissue Int. 2017;101:141–147. doi:10.1007/s00223-017-0265-4.

9. Ross FP. RANKing the importance of measles virus in Paget's disease. J Clin Invest. 2000;105(5):555-558. doi: 10.1172/JCI9557.

10. Numan MS, Jean S, Dessay M, Gagnon E, Amiable N, Brown JP, et al. Gene-environment interactions in Paget’s disease of bone. Jt. Bone Spine. 2019; 86: 373–380. doi:10.1016/j.jbspin.2018.12.007.

11. Deftos LJ. Treatment of Paget’s disease - taming the wild osteoclast. N Engl J Med 2005; 353: 872-875. doi: 10.1056/nejmp058184

12. Saki F, Karamizadeh Z, Nasirabadi S, Mumm S, McAlister WH, Whyte MP. Juvenile Paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. J Bone Miner Res. 2013;28(6):1501-1508. doi: 10.1002/jbmr.1868.

13. Kumar SRR, Bagalad BS, Manohar C, Kuberappa PH. Intermediate Type of Juvenile Paget’s Disease: A Rare Case in Indian Population. Contemp Clin Dent 2017;8:175-178.

14. Sahay M, Sahay R. Rickets-vitamin D deficiency and dependency. Indian J Endocrinol Metab. 2012;16(2):164-176. doi: 10.4103/2230-8210.93732.

15. Gennari L, Rendina D, Falchetti A, Merlotti D. Paget’s disease of bone. Calcif. Tissue Int. 2019; 104:483–500. doi:10.1007/s00223-019-00522-3

16. Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F. Primary hyperparathyroidism. Nat Rev Dis Primers. 2016;2:16033. doi: 10.1038/nrdp.2016.33.

17. Makaram NS, Ralston SH. Genetic determinants of Paget’s disease of bone. Curr. Osteoporos. Rep. 2021;19: 327–337. doi:10.1007/s11914-021-00676-w

18. Ralston SH, Corral-Gudino L, Cooper C, Francis R M, Fraser WD, Gennari L, et al. Diagnosis and management of Paget’s disease of bone in adults: A clinical guideline. J. Bone Min. Res. 2019; 34:579–604. doi:10.1002/jbmr.3657.

19. Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83(9):1032-1045. doi: 10.4065/83.9.1032.

Annals of Health Research Volume 12, Issue number 2 April-June 2026

Downloads

Published

2026-07-01

Issue

Section

Case Report

Most read articles by the same author(s)